91 Biggest Movers From Friday

Gainers

• RISE Education Cayman Ltd REDU shares jumped 138.5% to settle at $3.41 on Friday. RISE Education announced expected timing for the completion of the merger with Dada Auto.
• The Singing Machine Company, Inc. MICS gained 60.4% to settle at $6.72.
• Cogent Biosciences, Inc. COGT shares surged 58.7% to close at $7.87 on Friday after the company reported initial data from its ongoing Phase 2 APEX clinical trial.
• Alpha Tau Medical Ltd. DRTS rose 40.2% to settle at $9.66. Alpha Tau Medical recently announced FDA approval of its IDE application to initiate its multi-center pivotal study for the treatment of recurrent cutaneous Squamous Cell Carcinoma using the Alpha DaRT.
• Redbox Entertainment Inc. RDBX gained 39.4% to close at $13.20 on above-average volume as the stock trended across social media platforms.
• AeroClean Technologies, Inc. AERC jumped 38.7% to close at $12.50.
• BIMI International Medical Inc. BIMI rose 30% to settle at $0.6762 after the company announced it entered a $5 million stock purchase agreement with chairman Fnu Oudom.
• Aridis Pharmaceuticals, Inc. ARDS gained 29.2% to close at $1.46.
• Acurx Pharmaceuticals, Inc. ACXP rose 23.2% to settle at $3.77.
• Oxbridge Re Holdings Limited OXBR surged 19.9% to close at $4.34.
• Chicken Soup for the Soul Entertainment, Inc. CSSE gained 19.8% to close at $8.76.
• Nymox Pharmaceutical Corporation NYMX rose 19.7% to settle at $0.5296. Nymox Pharmaceutical, last month, received a Refusal to File letter from the FDA regarding the company's New Drug Application for fexapotide triflutate.
• Gold Resource Corporation GORO jumped 19.4% to close at $2.09. Gold Resource, last month, posted Q1 EPS of $0.05.
• Enservco Corporation ENSV gained 17.5% to close at $3.09.
• Quanergy Systems, Inc. QNGY surged 17.3% to close at $0.54.
• Borqs Technologies, Inc. BRQS shares gained 16.6% to close at $0.20.
• Arcellx, Inc. ACLX jumped 16.4% to settle at $24.43.
• Regis Corporation RGS jumped 16.3% to close at $0.65. Regis partnered with salon technology provider Zenoti to support its 5,000+ locations.
• Powerbridge Technologies Co., Ltd. PBTS gained 16.1% to close at $1.30 after jumping 190% on Thursday.
• Renovare Environmental, Inc. RENO rose 15.6% to settle at $0.2702.
• Bright Green Corporation BGXX gained 15.2% to close at $2.58.
• Snow Lake Resources Ltd. LITM jumped 14.8% to close at $4.58.
• Paltalk, Inc. PALT rose 14.7% to close at $2.23 after the company acquired Visicom's ManyCam assets for $2.7 million.
• Scopus BioPharma Inc. SCPS jumped 10.8% to close at $0.4490.
• New Oriental Education & Technology Group Inc. EDU rose 10.1% to close at $16.21 after dropping around 15% on Thursday.
• Energy Focus, Inc. EFOI gained 10% to close at $2.52. Energy Focus recently reported a $3.5 million private placement priced at-the-market under Nasdaq rules.
• Integrated Media Technology Limited IMTE gained 9.4% to close at $2.90. Integrated Media Technology announced Memorandum of Understanding to develop sourcing channel of halal products in Thailand.
• RLX Technology Inc. RLX shares gained 6.5% to close at $2.30.
• Data Storage Corporation DTST gained 6.4% to close at $3.34.
• Tenax Therapeutics, Inc. TENX surged 6% to close at $0.6524.

Losers

• Revlon, Inc. REV shares dipped 52.8% to close at $2.05. Revlon is reportedly close to filing for bankruptcy.
• ABVC BioPharma, Inc. ABVC declined 48.6% to settle at $0.90.
• Fulcrum Therapeutics, Inc. FULC shares fell 39.2% to close at $4.92 on Friday after the company announced clinical proof-of-concept data from the ongoing Phase 1b trial of FTX-6058 for the treatment of sickle cell disease.
• G Medical Innovations Holdings Ltd GMVD fell 28.5% to close at $0.3451 after declining 6% on Thursday.
• Axcella Health Inc. AXLA fell 27% to close at $2.00.
• Bluejay Diagnostics, Inc. BJDX declined 24.5% to settle at $1.23. Bluejay Diagnostics recently announced that the FDA has agreed to consider its plan to pursue a De Novo submission for the Symphony IL-6 Test.
• DocuSign, Inc. DOCU shares dropped 24.5% to close at $65.93 after the company reported weaker-than-expected earnings results for its first quarter. The company said it expects fiscal second-quarter revenue to be between $600 million and $604 million.
• Senti Biosciences, Inc. SNTI fell 24.1% to close at $4.80.
• Cosmos Holdings Inc. COSM fell 23% to close at $0.5776.
• Immuneering Corporation IMRX dipped 23% to settle at $4.95.
• Evelo Biosciences, Inc. EVLO fell 22.3% to close at $2.02.
• Boxed, Inc. BOXD dipped 21.9% to close at $1.96.
• Comtech Telecommunications Corp. CMTL declined 21.4% to close at $9.69 after the company reported worse-than-expected Q3 sales results.
• 17 Education & Technology Group Inc. YQ fell 21.3% to close at $2.40.
• Dave Inc. DAVE dipped 20.8% to close at $0.99.
• Greenwich LifeSciences, Inc. GLSI dropped 20.7% to close at $8.35.
• Applied Blockchain, Inc. APLD fell 20.6% to close at $2.74.
• Caribou Biosciences, Inc. CRBU dipped 20.4% to settle at $6.94 after the company reported additional data from the CB-010 allogeneic CAR-T cell therapy Phase 1 ANTLER trial at the European Hematology Association 2022 Hybrid Congress.
• Cyclerion Therapeutics, Inc. CYCN fell 20.2% to close at $0.6578 after the company announced topline clinical data for CY6463 in MELAS patients at UMDF Mitochondrial Medicine 2022 Symposium.
• Vivos Therapeutics, Inc. VVOS dipped 19.7% to close at $1.51. Vivos Therapeutics, last month, posted a Q1 loss of $0.26 per share.
• Troika Media Group, Inc. TRKA dropped 19.7% to close at $0.9401.
• Wejo Group Limited WEJO shares fell 19.5% to close at $1.57. Wejo recently announced the expansion and extension of its relationship with Microsoft Maps.
• Omega Therapeutics, Inc. OMGA dipped 19.5% to settle at $2.98.
• Lulu's Fashion Lounge Holdings, Inc. LVLU declined 19.5% to settle at $14.16. B of A Securities downgraded Lulus Fashion Lounge from Buy to Neutral and raised the price target from $14 to $21.
• UP Fintech Holding Limited TIGR fell 19% to close at $4.13 after the company reported Q1 earnings results.
• Ampio Pharmaceuticals, Inc. AMPE dropped 18.9% to close at $0.1835.
• Idera Pharmaceuticals, Inc. IDRA fell 18.8% to close at $0.53. Idera Pharmaceuticals, last month, reported results from an investigator-sponsored trial in melanoma patients.
• Vivint Smart Home, Inc. VVNT declined 18.8% to settle at $4.37.
• Stitch Fix, Inc. SFIX shares fell 18.5% to close at $6.34 after the company reported worse-than-expected results for its third quarter on Thursday. The company said it sees Q4 net revenue of $485 million to $495 million.
• Blueprint Medicines Corporation BPMC dipped 18.2% to close at $48.07 after Citigroup downgraded the stock from Neutral to Sell and lowered its price target from $68 to $41.
• Aptevo Therapeutics Inc. APVO declined 18.1% to close at $3.98. Aptevo Therapeutics recently announced new preliminary remission data on four additional patients enrolled in on-going APVO436 dose expansion Phase 1B Trial for the treatment of acute myeloid leukemia.
• Zynerba Pharmaceuticals, Inc. ZYNE fell 17.8% to close at $1.06.
• Rubius Therapeutics, Inc. RUBY fell 17.4% to settle at $0.9585.
• AnPac Bio-Medical Science Co., Ltd. ANPC dipped 17.3% to close at $0.2860. AnPac Bio regained compliance with requirements to remain listed on Nasdaq Capital Market.
• WeWork Inc. WE fell 17.2% to settle at $5.96.
• Qutoutiao Inc. QTT dropped 17.1% to settle at $1.41.
• Apyx Medical Corporation APYX fell 16.8% to close at $6.24. The U.S. Food and Drug Administration (FDA), last week, announced 510(k) clearance of Apyx Medical’s Renuvion Dermal Handpiece for specific dermal resurfacing procedures.
• Codiak BioSciences, Inc. CDAK fell 16.7% to close at $2.89.
• EBET, Inc. EBET fell 15.9% to settle at $3.02. EBET entered into securities purchase agreements with institutional and accredited investors to issue 0.97 million shares and warrants to buy up to an aggregate of 0.97 million shares.
• India Globalization Capital, Inc. IGC dipped 15.9% to close at $0.5231. IGC recently received U.S. Patent for method and composition for treating seizure disorders, utilizing CBD.
• 4D Molecular Therapeutics, Inc. FDMT fell 15.8% to close at $6.38.
• Werewolf Therapeutics, Inc. HOWL fell 15.7% to close at $4.62.
• Pear Therapeutics, Inc. PEAR fell 15.7% to settle at $2.31.
• Akouos, Inc. AKUS declined 15.6% to close at $4.18.
• Pineapple Energy Inc. PEGY fell 15.5% to close at $2.56.
• HyreCar Inc. HYRE dipped 15.3% to settle at $1.05.
• DBV Technologies S.A. DBVT fell 15.1% to close at $2.76 after jumping around 80% on Thursday. DBV Technologies announced private placement financing of $194 million.
• Valneva SE VALN fell 15% to close at $20.00.
• Opendoor Technologies Inc. OPEN dipped 14.8% to close at $5.70.
• Cepton, Inc. CPTN dropped 14.6% to settle at $1.46.
• Sonnet BioTherapeutics Holdings, Inc. SONN tumbled 14.4% to close at $0.2527. Sonnet BioTherapeutics recently announced results from a preclinical combination study of SON-1010 with anti-PD1 checkpoint inhibition.
• Freshworks Inc. FRSH fell 13.8% to close at $12.35.
• JanOne Inc. JAN fell 13.5% to close at $3.26. JanOne, on Thursday, said its ARCA Recycling subsidiary announced it will open three new recycling centers in June and July.
• NextPlay Technologies, Inc. NXTP shares declined 12.3% to close at $0.3074 after jumping 93% on Thursday.
• Quhuo Limited QH fell 10.4% to close at $0.43.
• Nisun International Enterprise Development Group Co., Ltd NISN fell 8.2% to close at $0.78 after the company announced a buyback of up to $8 million.
• View, Inc. VIEW fell 8.2% to close at $2.35.
• U.S. Well Services, Inc. USWS shares fell 8% to close at $0.8187 after the company announced it has received a written notice from NASDAQ that co. had failed to maintain compliance with the minimum bid requirement under Nasdaq listing rule.
• Selecta Biosciences, Inc. SELB fell 7.3% to settle at $1.14.
• Epizyme, Inc. EPZM fell 6.7% to close at $0.61 after declining around 8% on Thursday.
• GoodRx Holdings, Inc. GDRX slipped 5% to close at $6.43. Goldman Sachs downgraded GoodRx Holdings from Buy to Neutral and lowered the price target from $12 to $9.